Summary of Study ST001326

This data is available at the NIH Common Fund's National Metabolomics Data Repository (NMDR) website, the Metabolomics Workbench, https://www.metabolomicsworkbench.org, where it has been assigned Project ID PR000903. The data can be accessed directly via it's Project DOI: 10.21228/M8ZQ3Z This work is supported by NIH grant, U2C- DK119886.

See: https://www.metabolomicsworkbench.org/about/howtocite.php

This study contains a large results data set and is not available in the mwTab file. It is only available for download via FTP as data file(s) here.

Show all samples  |  Perform analysis on untargeted data  
Download mwTab file (text)   |  Download mwTab file(JSON)   |  Download data files (Contains raw data)
Study IDST001326
Study TitleUntargeted lipidome changes in Chlamydomonas reinhardtii treated with small molecules containing adamantane structures
Study SummaryA study to investigate the effect of small molecule lipid inducing compounds that leads to hyper accumulation of lipids in N replete cells of Chlamydomonas reinhardtii. These compounds were identified through a high throughput screening designed for that purpose. During that screening, we screened 43,783 compounds and identified 367 primary hits. These 367 hits were further retested using a 8-point dilution series (from 0.25 to 30 uM) and verified the activity of 250 compounds that induce the hyper lipid accumulating phenotype in algae. Once the hit compounds were identified and confirmed, we then performed extensive chemoinformatics analysis to look for common scaffolds and identified several common substructures. We then selected 15 top performing compounds from 5 diverse structural groups and tested biochemical parameters such as growth, lipid accumulating capacity, effect on photosynthetic rates, respiration rates, oxygen consumption rates, analysis of different lipid species to quantify and identify fatty acid species using GC-MS. To understand the global changes in the lipidome, 2 structurally similar compounds were selected and compared with cells grown without compounds as control for untargeted lipidome analysis.
Institute
University of Nebraska-Lincoln
DepartmentDepartment of Biochemistry
Last NameWase
First NameNishikant
AddressDepartment of Biochemistry, 1901 VINE STREET
Emailnishikant.wase@gmail.com
Phone4023109931
Submit Date2020-03-09
Raw Data AvailableYes
Raw Data File Type(s)mzXML
Analysis Type DetailLC-MS
Release Date2020-04-03
Release Version1
Nishikant Wase Nishikant Wase
https://dx.doi.org/10.21228/M8ZQ3Z
ftp://www.metabolomicsworkbench.org/Studies/ application/zip

Select appropriate tab below to view additional metadata details:


Project:

Project ID:PR000903
Project DOI:doi: 10.21228/M8ZQ3Z
Project Title:Untargeted lipidome changes in Chlamydomonas reinhardtii treated with small molecules containing adamantane structures
Project Summary:A study to investigate the effect of small molecule lipid inducing compounds that leads to hyper accumulation of lipids in N replete cells of Chlamydomonas reinhardtii. These compounds were identified through a high throughput screening designed for that purpose. During that screening, we screened 43,783 compounds and identified 367 primary hits. These 367 hits were further retested using a 8-point dilution series (from 0.25 to 30 uM) and verified the activity of 250 compounds that induce the hyper lipid accumulating phenotype in algae. Once the hit compounds were identified and confirmed, we then performed extensive chemoinformatics analysis to look for common scaffolds and identified several common substructures. We then selected 15 top performing compounds from 5 diverse structural groups and tested biochemical parameters such as growth, lipid accumulating capacity, effect on photosynthetic rates, respiration rates, oxygen consumption rates, analysis of different lipid species to quantify and identify fatty acid species using GC-MS. To understand the global changes in the lipidome, 2 structurally similar compounds were selected and compared with cells grown without compounds as control for untargeted lipidome analysis.
Institute:University of Nebraska-Lincoln
Department:Biochemistry
Laboratory:FATTTLab
Last Name:Wase
First Name:Nishikant
Address:1901 Beadle Center, Vine Street, 1901 VINE STREET, Lincoln, NE, 68588-0664, USA
Email:nishikant.wase@gmail.com
Phone:4023109931
Funding Source:NCESR-704, Nebraska Center for Energy Science Research; EPS-1004094 and 1264409, National Science Foundation ; NSF CBET : 1402896, National Science Foundation
Contributors:Nishikant Wase, Jiri Adamec, Ron Cerny, Girish Rasineni, Paul N Black, Concetta DiRusso

Subject:

Subject ID:SU001400
Subject Type:Photosynthetic organism
Subject Species:Chlamydomonas reinhardtii
Taxonomy ID:3055
Genotype Strain:CC125 Wild type

Factors:

Subject type: Photosynthetic organism; Subject species: Chlamydomonas reinhardtii (Factor headings shown in green)

mb_sample_id local_sample_id Group
SA096324Nplus_ACont
SA096325Nplus_CCont
SA096326Nplus_BCont
SA096327067_bWD20067
SA096328067_cWD20067
SA096329067_aWD20067
SA096330542_bWD20542
SA096331542_aWD20542
SA096332542_cWD20542
Showing results 1 to 9 of 9

Collection:

Collection ID:CO001395
Collection Summary:For lipid analysis, cells were grown in TAP media and treated with compounds at a final concentration of 5 µM. After 72h of growth, cells were harvested, media removed the biomass was lyophilized overnight at -50 °C. For lipid extraction dry biomass powder was accurately weighed 10 ± 0.5 milligram and resuspended in chloroform:methanol (2:1; 0.01% butylated hydroxytoluene (BHT)). The cell lysis was performed using bead mill (Qiagen TissueLyser LT, Qiagen Valencia, CA) for 5 min at 50 Hz power and further incubated for 30 min in a multi-tube vortexer (Fischer Scientific). Lower lipid phase was retrieved and transferred to a new clean tube and samples re-extracted. Both lipid phases were pooled together lipids were shaken first with 0.8% aqueous potassium chloride solution and then water. The organic phase was transferred to fresh tube and evaporated under the stream of nitrogen. The dried lipid samples were flushed with nitrogen and stored at -80 °C until analyzed on FT-MS.
Sample Type:Algae
Collection Method:Centrifugation from suspension culture.
Collection Location:FATTTLab Department of Biochemistry, Univ of Nebraska-Lincoln
Storage Conditions:After harvest, cells were kept at -80 C until extraction.
Collection Vials:2 mL Eppendorf tubes

Treatment:

Treatment ID:TR001415
Treatment Summary:For compound treatment, cells from mid-log phase culture were harvested, washed once with fresh sterile TAP media and inoculated at starting density of 5 x 105 cells/mL. Thus for the current experiment 3 different treatment conditions were generated. Cells without compound treatment were negative control for the lipid accumulation and 2 compounds were used to generate treatment conditions. All compounds were used at a final concentration of 5 uM (this concentration was determined using a dose-response curve). For all cultures, 250 mL Erlenmeyer flasks with rubber stopper adopted to facilitate gas exchange were used and maintained in horizontal orbital shaking growing chamber (Innova 43; New Brunswick). At the end of 72h, cells were harvested, media was removed via centrifugation and biomass was stored at -80 C until lipids extraction.

Sample Preparation:

Sampleprep ID:SP001408
Sampleprep Summary:For lipid analysis, cells were grown in TAP media and treated with compounds at a final concentration of 5 µM. After 72h of growth, cells were harvested, media removed the biomass was lyophilized overnight at -50 °C. For lipid extraction dry biomass powder was accurately weighed 10 ± 0.5 milligram and resuspended in chloroform:methanol (2:1; 0.01% butylated hydroxytoluene (BHT)). The cell lysis was performed using bead mill (Qiagen TissueLyser LT, Qiagen Valencia, CA) for 5 min at 50 Hz power and further incubated for 30 min in a multi-tube vortexer (Fischer Scientific). Lower lipid phase was retrieved and transferred to a new clean tube and samples re-extracted. Both lipid phases were pooled together lipids were shaken first with 0.8% aqueous potassium chloride solution and then water. The organic phase was transferred to fresh tube and evaporated under the stream of nitrogen. The dried lipid samples were flushed with nitrogen and stored at -80 °C until analyzed on FT-MS.
Extraction Method:Bead beating

Combined analysis:

Analysis ID AN002208
Analysis type MS
Chromatography type Reversed phase
Chromatography system Agilent 1200 Series HPLC
Column ACE 5 C8-300 (100 x 2.1mm)
MS Type ESI
MS instrument type FT-ICR
MS instrument name Bruker Solarix FT-ICR-MS
Ion Mode POSITIVE
Units intesity

Chromatography:

Chromatography ID:CH001619
Chromatography Summary:The dried lipid samples were retrieved from -80 °C and dissolved into methanol:chloroform (1:1). FTICR-MS analysis was performed using an Agilent 1200 Series HPCL coupled to a 7.05 T Solarix FT-ICR (Bruker) equipped with an ESI source and controlled by HyStar v3.4.8.0 software. Five microliter of samples were injected onto an Ace 5 C8-300 column (2.1 x 100 mm) at a flow rate of 0.1 ml/min. Initial HPLC conditions consisted of 70% Solvent A (0.1% FA; 10 mM ammonium acetate in water) and 30% Solvent B (0.1% FA; 10 mM ammonium acetate in acetonitrile). Samples were eluted using the following gradient: 30% B held for 1 minute, increased to 100% B over 24 minutes and held for 20 minutes. The column was returned to initial conditions of 30% B over 2 minutes then allowed to re-equilibrate over 13 minutes.
Instrument Name:Agilent 1200 Series HPLC
Column Name:ACE 5 C8-300 (100 x 2.1mm)
Flow Rate:0.1 mL/min
Sample Injection:5 uL
Solvent A:100% water; 0.1% formic acid; 10 mM ammonium acetate
Solvent B:100% acetonitrile; 0.1% formic acid; 10 mM ammonium acetate
Chromatography Type:Reversed phase

MS:

MS ID:MS002054
Analysis ID:AN002208
Instrument Name:Bruker Solarix FT-ICR-MS
Instrument Type:FT-ICR
MS Type:ESI
MS Comments:Accurate MS analysis was performed on Bruker 7.05 T Solarix FT-ICR. Mass spectra were acquired in the positive ionization mode from m/z 150.58 to 2500 at a resolving power of 49,000. Capillary voltage was 4500 V with the end plate offset voltage set to -500 V. Drying temperature was set to 180 °C and with a drying gas flow rate of 4 L/min and nebulizer gas flow set to 1.0 bar. Immediately prior to acquisition the instrument was calibrated in the positive ESI mode using NaTFA clusters. Raw MS spectra were converted to mzXML format using CompassXport v. 3.0.6 and processed by Mzmine v 2.2.4. Feature detection was done on the centrioded data using a noise level of 1.0E06 intensity. Once the masses were detected then FTMS shoulder peak filtering was performed using Lorentzian extended algorithm and chromatograms were build using a min time span of 0.1 min, minimum height of 1.0E06 intensity and m/z tolerance was set at 10 ppm. Peak smoothing was performed using Savitzky-Golay algorithm with a filter width of 3. Chromatograms were deconvulated using Savitzky-Golay algorithm using minimum peak height set at 1.0E06 intensity. Finally all the peak lists were aligned using Join aligner method using mz tolerance of 10 ppm, RT tolerance of 0.5 min. The aligned peak list rows were filtered using duplicated peak list filter to obtain 3448 peaks. The missing peak data was recovered using the Gap filling method using the intensity tolerance of 0.1, mz tolerance of 10 ppm and RT tolerance of 0.5 min. RT correction was allowed at this stage. These peaks were identified using Lipid Search module within the mzMine 2. Potential lipids were annotated according to there accurate mass on MS1 level with following setting. Minimum number of carbon set to 28 and max to 60, max number of double bonds set to 10, m/z tolerance was set to 0.001 Da. Then search was performed with two ionization mode [M+H]+ and [M+NH4]+ to obtain identification on 353 peaks. Peak areas along with identification, m/z, retention time were exported out and brought into R environment for univariate and multivariate analysis.
Ion Mode:POSITIVE
  logo